University of California, San Francisco.
Drug Industry Document Archives.

Title: URGENT ACTION – Trial 41 dissemination
Document Date: 20020910
Document Type: email
Collection: Seroquel Products Liability
Bates Number: azser3777919-azser3777920
Exhibit Number: Beamish 27
Date Added UCSF: 20100219
Page Count: 2
Description: Transparency/Concealing Data; Efficacy; Study 41; Email from Seroquel Global Brand Manager, Simon Hagger, on behalf of the Seroquel SR Communications Team advising that they are under clear instruction from the highest level in AZ not to discuss details surrounding Trial 41 with any external partners, which would include study investigators.
Company: AstraZeneca
Casename: Seroquel Products Litigation, 06-MD-01769, US District Court, Middle District of Florida
View as: PDF
Legal      Privacy      Contact Us

  UCSF Library University of California, San Francisco ©2011 The Regents of the University of California